TYROBP and cancer: As a conserved and immune-related network across multiple cancer types, some molecules in the SPI1-TYROBP(i.e., KARAP or DAP12)-FCER1G network have been identified as prognostic biomarkers before in other cancer types [38–41] and OS [42–44].